|
Colorectal Neoplasms
|
0.700 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association study of colorectal cancer in Hispanics.
|
27207650 |
2016 |
|
Colorectal Neoplasms
|
0.700 |
Therapeutic
|
group |
RGD |
Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer.
|
23149858 |
2013 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
BEFREE |
Herein we show that MMP-2 is up-regulated in resected colorectal tumors and degrades β1 integrins with the release of fragments containing the β1 I-domain.
|
22898815 |
2012 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
CTD_human |
Genomic and epigenomic integration identifies a prognostic signature in colon cancer.
|
21278247 |
2011 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
BEFREE |
The high expressions of MMP2 and MMP9 were closely associated with invasion and migration of colorectal tumors and cell lines.
|
20191032 |
2010 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
|
18425389 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
CTD_human |
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.
|
18507500 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not.
|
18506186 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese.
|
17546628 |
2007 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases.
|
18214299 |
2007 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
BEFREE |
Matrix metalloproteinase (MMP)-7 (matrilysin-1) plays significant roles in the growth, invasion, and metastasis of colorectal tumors, while (-)-epigallocatechin-3-gallate (EGCG), a green tea polyphenol with chemopreventive properties, has been shown to be an inhibitor of MMP-2 and MMP-9.
|
15860507 |
2005 |
|
Colorectal Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
|
15485653 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Laminin-5 gamma 2 chain and matrix metalloproteinase-2 may trigger colorectal carcinoma invasiveness through formation of budding tumor cells.
|
14666611 |
2003 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
|
14520690 |
2003 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
BEFREE |
Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium.
|
12184536 |
2002 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
BEFREE |
We evaluated levels and activity of gelatinase A (MMP-2) and gelatinase B (MMP-9), as well as stromelysin-1 (MMP-3) expression in 101 sporadic colorectal tumors in consideration of the microsatellite instability (MSI) status of the groups.
|
12097300 |
2002 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
BEFREE |
Matrilysin and gelatinase A, B mRNA expressions were examined in colorectal tumors.
|
8913260 |
1996 |